| Literature DB >> 32369929 |
Jung-Whan Chon1, Un Jung Lee2, Ryan Bensen3, Stephanie West4, Angel Paredes5, Jinhee Lim5, Saeed Khan1, Mark E Hart1,6, K Scott Phillips7, Kidon Sung1.
Abstract
Coagulase-negative staphylococci (CoNS) are an important group of opportunistic pathogenic microorganisms that cause infections in hospital settings and are generally resistant to many antimicrobial agents. We report on phenotypic and genotypic virulence characteristics of a select group of clinical, mecA-positive (encoding penicillin-binding protein 2a) CoNS isolates. All CoNS were resistant to two or more antimicrobials with S. epidermidis strain 214EP, showing resistance to fifteen of the sixteen antimicrobial agents tested. Aminoglycoside-resistance genes were the ones most commonly detected. The presence of megaplasmids containing both horizontal gene transfer and antimicrobial resistance genetic determinants indicates that CoNS may disseminate antibiotic resistance to other bacteria. Staphylococcus sciuri species produced six virulence enzymes, including a DNase, gelatinase, lipase, phosphatase, and protease that are suspected to degrade tissues into nutrients for bacterial growth and contribute to the pathogenicity of CoNS. The PCR assay for the detection of biofilm-associated genes found the eno (encoding laminin-binding protein) gene in all isolates. Measurement of their biofilm-forming ability and Spearman's rank correlation coefficient analyses revealed that the results of crystal violet (CV) and extracellular polymeric substances (EPS) assays were significantly correlated (ρ = 0.9153, P = 3.612e-12). The presence of virulence factors, biofilm-formation capability, extracellular enzymes, multidrug resistance, and gene transfer markers in mecA-positive CoNS clinical strains used in this study makes them powerful opportunistic pathogens. The study also warrants a careful evaluation of nosocomial infections caused by CoNS and may be useful in studying the mechanism of virulence and factors associated with their pathogenicity in vivo and developing effective strategies for mitigation.Entities:
Keywords: coagulase-negative staphylococci; multidrug-resistant; virulence
Year: 2020 PMID: 32369929 PMCID: PMC7284987 DOI: 10.3390/microorganisms8050659
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Phenotypic and genotypic antimicrobial resistance and transfer genes in clinical coagulase-negative staphylococci (CoNS) isolates.
| Strain | Species | Source | AMP | BAC | CEF | CIP | ERY | GEN | KAN | LIN | NOV | OXA | PEN | POL | RIF | STR | TET | VAN | Antibiotic Resistance and Transfer Genes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10SC |
| Nasal |
| ||||||||||||||||
| 20SC |
| Nasal |
| ||||||||||||||||
| 30SC |
| Nasal |
| ||||||||||||||||
| 40SC |
| Nasal |
| ||||||||||||||||
| 50SC |
| Nasal |
| ||||||||||||||||
| 60SC |
| Nasal |
| ||||||||||||||||
| 70SC |
| Nasal |
| ||||||||||||||||
| 80SC |
| Nasal |
| ||||||||||||||||
| 91HA |
| Arterial line catheter |
| ||||||||||||||||
| 101HA |
| Nasal |
| ||||||||||||||||
| 111HA |
| Nasal |
| ||||||||||||||||
| 121HA |
| Nasal |
| ||||||||||||||||
| 132LE |
| Nasal |
| ||||||||||||||||
| 143AU |
| NA |
| ||||||||||||||||
| 153AU |
| Blood |
| ||||||||||||||||
| 163AU |
| Blood |
| ||||||||||||||||
| 174EP |
| Blood |
| ||||||||||||||||
| 184EP |
| Wound foot |
| ||||||||||||||||
| 194EP |
| Wound buttock |
| ||||||||||||||||
| 204EP |
| NA |
| ||||||||||||||||
| 214EP |
| Arterial line catheter |
| ||||||||||||||||
| 224EP |
| Perirectal |
| ||||||||||||||||
| 235HO |
| Blood |
| ||||||||||||||||
| 245HO |
| Wound foot |
| ||||||||||||||||
| 255HO |
| Urine |
| ||||||||||||||||
| 266LU |
| Wound foot |
| ||||||||||||||||
| 276LU |
| Arm abscess |
| ||||||||||||||||
| 287SI |
| Wound thigh |
| ||||||||||||||||
| 297SI |
| Blood |
|
* AMP: Ampicillin, BAC: Bacitracin, CEF: Cefazolin, CIP: Ciprofloxacin, ERY: Erythromycin, GEN: Gentamicin, KAN: Kanamycin, LIN: Lincomycin, NOV: Novobiocin, OXA: Oxacillin, PEN: Penicillin, POL: Polymyxin B, RIF: Rifampicin, STR: Streptomycin, TET: Tetracycline, VAN: Vancomycin, ** Solid: Resistant, Grey: Intermediate, Clear: Sensitive. *** Antimicrobial resistance genes are regular and transfer genes are bold; str, tetM, tetS, tetW, class I integron, nespSK41, traE, traG, traK, and traM were PCR-negative for all CoNS. **** NA: Source is not available.
Figure 1Plasmid DNA profiles of Staphylococcus species. Agarose gel electrophoresis (0.8%) was run at 100 V for 4 h and a supercoiled DNA ladder from Agilent Technologies was used as a molecular size marker. First and last lanes are supercoiled plasmid DNA ladders. Staphylococcus strains in lanes 1-29—10SC, 20SC, 30SC, 40SC, 50SC, 60SC, 70SC, 80SC, 91HA, 101HA, 111HA, 121HA, 132LE, 143AU, 153AU, 163AU, 174EP, 184EP, 194EP, 204EP, 214EP, 224EP, 235HO, 245HO, 255HO, 266LU, 276LU, 287SI, and 297SI.
Phenotypic virulence enzymes in clinical CoNS isolates.
| Strain | COG | DNA | GEL | LIP | PHO | PRO | URE |
|---|---|---|---|---|---|---|---|
| 10SC | − | + | − | + | + | − | − |
| 20SC | − | + | + | + | + | + | − |
| 30SC | − | + | + | + | + | + | − |
| 40SC | − | + | + | + | + | + | − |
| 50SC | − | + | − | + | + | − | − |
| 60SC | − | + | + | + | + | + | − |
| 70SC | − | + | + | + | + | + | − |
| 80SC | − | + | − | + | + | − | − |
| 91HA | − | + | − | − | − | − | − |
| 101HA | − | + | − | − | − | − | − |
| 111HA | − | + | − | − | − | − | − |
| 121HA | − | + | − | − | − | − | − |
| 132LE | − | − | − | + | + | − | − |
| 143AU | − | + | − | + | − | − | − |
| 153AU | − | + | − | + | − | − | − |
| 163AU | − | + | − | + | − | − | − |
| 174EP | − | + | − | + | + | + | + |
| 184EP | − | + | − | − | − | − | + |
| 194EP | − | + | − | + | − | − | + |
| 204EP | − | + | − | + | + | − | + |
| 214EP | − | + | − | + | + | − | + |
| 224EP | − | + | − | − | + | − | + |
| 235HO | − | − | − | − | − | − | + |
| 245HO | − | + | − | + | − | − | − |
| 255HO | − | + | − | − | − | − | + |
| 266LU | − | + | − | + | + | − | + |
| 276LU | − | + | − | + | + | − | + |
| 287SI | − | + | − | + | − | − | + |
| 297SI | − | + | − | − | − | − | + |
* COG: Coagulase, DNA: DNase, GEL: Gelatinase, LIP: Lipase, PHO: Phosphatase, URE: Urease, PRO: Protease. ** +: positive, −: negative.
Genotypic virulence factors in clinical CoNS isolates.
| Strain |
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| 10SC | + | − | - | - | − | − | − | − | − |
| 20SC | + | − | − | − | − | − | + | − | − |
| 30SC | + | − | − | − | − | − | + | − | − |
| 40SC | + | − | − | − | − | − | + | − | − |
| 50SC | + | − | − | − | − | − | + | − | − |
| 60SC | + | + | − | + | − | − | + | − | − |
| 70SC | + | − | − | − | − | − | + | − | − |
| 80SC | + | − | − | + | − | − | − | − | − |
| 91HA | + | − | − | − | − | − | − | − | − |
| 101HA | + | − | − | − | − | − | − | − | − |
| 111HA | + | − | − | − | − | − | − | − | − |
| 121HA | + | + | − | − | − | − | + | − | − |
| 132LE | + | − | − | + | − | − | − | − | − |
| 143AU | + | − | − | + | − | + | − | − | − |
| 153AU | + | − | + | + | − | − | − | − | − |
| 163AU | + | − | + | + | − | − | − | − | − |
| 174EP | + | + | − | + | + | − | + | + | + |
| 184EP | + | − | − | + | − | − | − | − | − |
| 194EP | + | − | − | + | − | − | + | − | − |
| 204EP | + | − | − | − | − | − | − | − | − |
| 214EP | + | − | − | + | − | − | + | + | + |
| 224EP | + | − | − | − | − | − | − | − | − |
| 235HO | + | − | − | − | − | − | − | − | − |
| 245HO | + | − | − | − | − | − | − | − | − |
| 255HO | + | − | − | − | − | − | − | − | − |
| 266LU | + | − | − | + | − | − | + | − | − |
| 276LU | + | − | − | + | − | − | + | − | − |
| 287SI | + | − | − | + | − | − | + | − | − |
| 297SI | + | − | − | + | − | − | − | − | − |
* All negative results in genotypic tests—cna, ebpS, fnbA, bbp, hla, hlb, sea, seb, sec, sed, see, seg, seh, sei, sej, Tst, eta, etb, pvl.
Figure 2Biofilm formation of Staphylococcus species shown by crystal violet (CV) staining. Experiments were run in triplicate and each bar represents the mean ± standard deviation from the mean.
Figure 3Biofilm formation of Staphylococcus species shown by extracellular polymeric substances (EPS) assay. Experiments were run in triplicate and each bar represents the mean ± standard deviation from the mean.
Figure 4Biofilm formation of Staphylococcus species shown by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Experiments were run in triplicate and each bar represents the mean ± standard deviation from the mean.
Figure 5Principal component analysis (PCA) of crystal violet (CV), extracellular polymeric substances (EPS), and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assays.
Pairwise Spearman rank order correlation coefficient (ρ) for biofilm analysis methods.
| EPS | CV | |
|---|---|---|
| CV | ρ: 9.153 × 10−1 | |
| MTT | ρ: 6.677 × 10−1 | ρ: 6.418 × 10−1 |
Figure 6Field emission scanning electron microscopy (FESEM) images of biofilm. The scale bar in all the images corresponds to 1.0 μm. (A): S. sciuri strain 10SC, (B): S. sciuri strain 70SC, (C): S. lugdunensis strain 266LU, (D): S. simulans strain 297SI.
Figure 7NS-TEM images of biofilm. The scale bar in all the images corresponds to 1.0 μm. (A): S. sciuri strain 10SC, (B): S. sciuri strain 70SC, (C): S. lugdunensis strain 266LU, (D): S. simulans strain 297SI.